Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningioma | 25 | 2023 | 1222 | 4.740 |
Why?
|
Meningeal Neoplasms | 22 | 2023 | 1251 | 4.200 |
Why?
|
Glioma | 36 | 2023 | 3523 | 2.980 |
Why?
|
Brain Neoplasms | 44 | 2023 | 9182 | 2.340 |
Why?
|
Neurosurgical Procedures | 7 | 2019 | 2097 | 0.850 |
Why?
|
Radiography, Dental | 2 | 2012 | 51 | 0.820 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 7 | 2005 | 934 | 0.780 |
Why?
|
Aneurysm, Ruptured | 2 | 2018 | 469 | 0.680 |
Why?
|
Breast Neoplasms | 30 | 2017 | 21156 | 0.650 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2012 | 555 | 0.610 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2023 | 954 | 0.600 |
Why?
|
Intracranial Aneurysm | 4 | 2023 | 1318 | 0.600 |
Why?
|
Radiosurgery | 7 | 2019 | 1354 | 0.580 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2018 | 410 | 0.570 |
Why?
|
Case-Control Studies | 30 | 2023 | 22293 | 0.560 |
Why?
|
Polymorphism, Single Nucleotide | 14 | 2019 | 16029 | 0.520 |
Why?
|
Craniotomy | 5 | 2017 | 748 | 0.490 |
Why?
|
Estrogen Replacement Therapy | 3 | 2012 | 1209 | 0.490 |
Why?
|
Carcinoma in Situ | 3 | 2012 | 791 | 0.480 |
Why?
|
Soybean Proteins | 1 | 2014 | 55 | 0.450 |
Why?
|
Connecticut | 8 | 2017 | 365 | 0.450 |
Why?
|
Genetic Predisposition to Disease | 21 | 2023 | 18048 | 0.430 |
Why?
|
Central Nervous System Neoplasms | 4 | 2022 | 928 | 0.420 |
Why?
|
Embolization, Therapeutic | 2 | 2023 | 1435 | 0.410 |
Why?
|
Family Health | 5 | 2013 | 1256 | 0.410 |
Why?
|
Molecular Targeted Therapy | 2 | 2023 | 2834 | 0.400 |
Why?
|
Receptors, Progesterone | 5 | 2022 | 1145 | 0.400 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2012 | 1092 | 0.390 |
Why?
|
Reproductive History | 1 | 2012 | 210 | 0.380 |
Why?
|
Spinal Cord Neoplasms | 2 | 2012 | 263 | 0.370 |
Why?
|
Genome-Wide Association Study | 13 | 2019 | 12774 | 0.370 |
Why?
|
Spinal Fusion | 2 | 2011 | 1310 | 0.360 |
Why?
|
Leukocytes | 1 | 2019 | 2030 | 0.360 |
Why?
|
Middle Aged | 76 | 2023 | 223418 | 0.360 |
Why?
|
Genes, BRCA1 | 3 | 2005 | 755 | 0.340 |
Why?
|
Genetic Loci | 2 | 2019 | 2630 | 0.340 |
Why?
|
Models, Genetic | 7 | 2019 | 3442 | 0.340 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2010 | 79 | 0.340 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1897 | 0.330 |
Why?
|
Female | 96 | 2023 | 396943 | 0.330 |
Why?
|
Adult | 71 | 2023 | 223542 | 0.320 |
Why?
|
Body Mass Index | 7 | 2019 | 13030 | 0.320 |
Why?
|
Carcinoma, Lobular | 2 | 2003 | 480 | 0.320 |
Why?
|
Humans | 129 | 2023 | 768451 | 0.310 |
Why?
|
Aged | 58 | 2019 | 171520 | 0.300 |
Why?
|
Smoking | 4 | 2012 | 9099 | 0.300 |
Why?
|
Risk Factors | 45 | 2020 | 74915 | 0.300 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2011 | 848 | 0.290 |
Why?
|
Lumbar Vertebrae | 3 | 2012 | 1885 | 0.290 |
Why?
|
Medical History Taking | 1 | 2011 | 776 | 0.290 |
Why?
|
Salvage Therapy | 5 | 2018 | 1277 | 0.280 |
Why?
|
Spinal Diseases | 1 | 2011 | 563 | 0.270 |
Why?
|
Contraceptives, Oral | 2 | 2012 | 562 | 0.270 |
Why?
|
Hypersensitivity | 3 | 2016 | 1172 | 0.260 |
Why?
|
Male | 63 | 2023 | 364781 | 0.260 |
Why?
|
Hospital Mortality | 2 | 2018 | 5371 | 0.260 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.260 |
Why?
|
Genetic Linkage | 6 | 2018 | 2342 | 0.260 |
Why?
|
Mendelian Randomization Analysis | 4 | 2020 | 1036 | 0.260 |
Why?
|
Prognosis | 20 | 2022 | 30028 | 0.260 |
Why?
|
Ovarian Neoplasms | 7 | 2003 | 4906 | 0.250 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2008 | 410 | 0.240 |
Why?
|
Accidental Falls | 5 | 1996 | 1081 | 0.240 |
Why?
|
Oncogenes | 3 | 1996 | 1235 | 0.240 |
Why?
|
Supratentorial Neoplasms | 1 | 2006 | 159 | 0.240 |
Why?
|
Immunoglobulin E | 1 | 2011 | 1510 | 0.240 |
Why?
|
North Carolina | 2 | 2017 | 327 | 0.240 |
Why?
|
Quality of Life | 3 | 2023 | 13497 | 0.230 |
Why?
|
Genes, BRCA2 | 2 | 2005 | 592 | 0.230 |
Why?
|
Spinal Neoplasms | 1 | 2011 | 715 | 0.230 |
Why?
|
Glioblastoma | 5 | 2018 | 3523 | 0.230 |
Why?
|
Breast Feeding | 1 | 2012 | 1365 | 0.230 |
Why?
|
Texas | 2 | 2017 | 405 | 0.230 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2258 | 0.230 |
Why?
|
Genotype | 11 | 2019 | 13047 | 0.230 |
Why?
|
Risk | 10 | 2019 | 9642 | 0.220 |
Why?
|
Autoantibodies | 1 | 2012 | 2131 | 0.220 |
Why?
|
Receptors, Estrogen | 6 | 2023 | 2243 | 0.220 |
Why?
|
Length of Stay | 3 | 2018 | 6521 | 0.220 |
Why?
|
Sex Factors | 10 | 2022 | 10647 | 0.210 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1376 | 0.210 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13708 | 0.200 |
Why?
|
Young Adult | 25 | 2018 | 60045 | 0.200 |
Why?
|
Neoplasms, Second Primary | 2 | 2015 | 1062 | 0.200 |
Why?
|
Odds Ratio | 9 | 2019 | 9687 | 0.200 |
Why?
|
Reoperation | 4 | 2017 | 4342 | 0.190 |
Why?
|
Disease Management | 1 | 2011 | 2533 | 0.180 |
Why?
|
Mutation | 8 | 2023 | 30243 | 0.170 |
Why?
|
Aneurysm | 1 | 2023 | 338 | 0.170 |
Why?
|
SEER Program | 3 | 2011 | 1476 | 0.170 |
Why?
|
Frail Elderly | 2 | 1996 | 774 | 0.160 |
Why?
|
Survival Rate | 7 | 2019 | 12875 | 0.160 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 2015 | 419 | 0.160 |
Why?
|
Postoperative Complications | 7 | 2017 | 15880 | 0.160 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39430 | 0.150 |
Why?
|
Receptor, erbB-2 | 5 | 2017 | 2586 | 0.150 |
Why?
|
Treatment Outcome | 18 | 2023 | 65409 | 0.150 |
Why?
|
United States | 17 | 2018 | 73121 | 0.150 |
Why?
|
Activities of Daily Living | 5 | 2017 | 2433 | 0.150 |
Why?
|
Aged, 80 and over | 23 | 2019 | 59680 | 0.150 |
Why?
|
Age Factors | 14 | 2018 | 18478 | 0.140 |
Why?
|
Germ-Line Mutation | 3 | 2014 | 1884 | 0.140 |
Why?
|
Risk Assessment | 9 | 2019 | 24311 | 0.140 |
Why?
|
Informed Consent | 1 | 2023 | 1012 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 9425 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 8635 | 0.130 |
Why?
|
Calcifediol | 1 | 2017 | 160 | 0.130 |
Why?
|
Epidemiologic Methods | 1 | 2000 | 1337 | 0.130 |
Why?
|
Family | 4 | 2015 | 3208 | 0.130 |
Why?
|
Linkage Disequilibrium | 2 | 2018 | 1998 | 0.130 |
Why?
|
Chickenpox | 1 | 2016 | 96 | 0.120 |
Why?
|
Pedigree | 9 | 2015 | 4545 | 0.120 |
Why?
|
Heterozygote | 2 | 1998 | 2792 | 0.120 |
Why?
|
Proportional Hazards Models | 8 | 2017 | 12561 | 0.120 |
Why?
|
Quality Improvement | 4 | 2017 | 3858 | 0.120 |
Why?
|
Registries | 7 | 2017 | 8373 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 1 | 1998 | 1064 | 0.110 |
Why?
|
Biomedical Research | 1 | 2010 | 3463 | 0.110 |
Why?
|
Mammography | 4 | 2008 | 2436 | 0.110 |
Why?
|
Telomere-Binding Proteins | 1 | 2014 | 122 | 0.110 |
Why?
|
Socioeconomic Factors | 3 | 2012 | 7863 | 0.110 |
Why?
|
MutS Homolog 2 Protein | 1 | 2014 | 200 | 0.110 |
Why?
|
Molecular Epidemiology | 1 | 2015 | 473 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2019 | 1794 | 0.110 |
Why?
|
California | 1 | 2017 | 1444 | 0.110 |
Why?
|
Morpholines | 1 | 2016 | 583 | 0.110 |
Why?
|
Adolescent | 20 | 2018 | 89168 | 0.100 |
Why?
|
Serum Albumin | 1 | 2016 | 676 | 0.100 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2012 | 38 | 0.100 |
Why?
|
Incidence | 10 | 2017 | 21552 | 0.100 |
Why?
|
Counseling | 1 | 2001 | 1548 | 0.100 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2012 | 127 | 0.100 |
Why?
|
San Francisco | 1 | 2012 | 166 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2884 | 0.100 |
Why?
|
Aminopyridines | 1 | 2016 | 578 | 0.100 |
Why?
|
Antigens, Nuclear | 1 | 2012 | 184 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2011 | 6537 | 0.100 |
Why?
|
Logistic Models | 7 | 2018 | 13324 | 0.100 |
Why?
|
Massachusetts | 2 | 2017 | 8908 | 0.100 |
Why?
|
Dacarbazine | 1 | 2015 | 560 | 0.100 |
Why?
|
Cohort Studies | 10 | 2022 | 41797 | 0.100 |
Why?
|
Age of Onset | 3 | 2012 | 3342 | 0.100 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1992 | 61 | 0.100 |
Why?
|
Retrospective Studies | 18 | 2023 | 81834 | 0.100 |
Why?
|
Health Facility Size | 1 | 2011 | 61 | 0.090 |
Why?
|
Melanoma | 3 | 2017 | 5740 | 0.090 |
Why?
|
Neoplasms | 5 | 2023 | 22386 | 0.090 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2010 | 300 | 0.090 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 252 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2015 | 618 | 0.090 |
Why?
|
Medicare Part A | 1 | 2011 | 40 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2643 | 0.090 |
Why?
|
Linear Models | 2 | 2011 | 5880 | 0.090 |
Why?
|
Eczema | 1 | 2012 | 246 | 0.090 |
Why?
|
Genes, p16 | 1 | 2010 | 160 | 0.090 |
Why?
|
Nevus | 1 | 1992 | 206 | 0.080 |
Why?
|
Genomics | 3 | 2023 | 5909 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1112 | 0.080 |
Why?
|
Menarche | 1 | 2012 | 538 | 0.080 |
Why?
|
Parity | 1 | 2012 | 939 | 0.080 |
Why?
|
Models, Statistical | 2 | 2001 | 5103 | 0.080 |
Why?
|
Geography | 1 | 2011 | 654 | 0.080 |
Why?
|
International Cooperation | 1 | 2015 | 1439 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2008 | 7451 | 0.080 |
Why?
|
Dental Care | 1 | 2012 | 285 | 0.080 |
Why?
|
Primary Prevention | 1 | 1996 | 1189 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2279 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2011 | 386 | 0.080 |
Why?
|
Survival Analysis | 3 | 2017 | 10125 | 0.080 |
Why?
|
Mental Health | 2 | 2017 | 3271 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2023 | 2819 | 0.080 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1991 | 249 | 0.080 |
Why?
|
Chromosome Mapping | 4 | 2012 | 4622 | 0.080 |
Why?
|
Genes, p53 | 1 | 2010 | 716 | 0.070 |
Why?
|
Patient Discharge | 2 | 2018 | 3471 | 0.070 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1183 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 1544 | 0.070 |
Why?
|
Attitude to Health | 2 | 2008 | 2030 | 0.070 |
Why?
|
Alleles | 6 | 2018 | 6890 | 0.070 |
Why?
|
Hospital Charges | 1 | 2009 | 351 | 0.070 |
Why?
|
Insurance Claim Review | 1 | 2011 | 745 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2017 | 1389 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2067 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3437 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3139 | 0.070 |
Why?
|
Hormones | 1 | 1991 | 870 | 0.070 |
Why?
|
Neurilemmoma | 1 | 2012 | 524 | 0.070 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2008 | 348 | 0.070 |
Why?
|
Tumor Burden | 3 | 2019 | 1909 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2018 | 8559 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2012 | 1415 | 0.070 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 730 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2046 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 1995 | 2518 | 0.060 |
Why?
|
Obesity | 2 | 2019 | 13065 | 0.060 |
Why?
|
Legislation as Topic | 1 | 2005 | 76 | 0.060 |
Why?
|
Steroids | 1 | 1991 | 937 | 0.060 |
Why?
|
Genetic Markers | 3 | 2007 | 2604 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2016 | 2932 | 0.060 |
Why?
|
Prospective Studies | 8 | 2019 | 54914 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2023 | 11138 | 0.060 |
Why?
|
Cell Cycle Proteins | 2 | 2016 | 3463 | 0.060 |
Why?
|
Child, Preschool | 8 | 2017 | 42623 | 0.060 |
Why?
|
Seizures | 1 | 2018 | 2996 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2017 | 5891 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14766 | 0.060 |
Why?
|
Patient Compliance | 2 | 2005 | 2696 | 0.060 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 613 | 0.060 |
Why?
|
Diet | 2 | 2020 | 8098 | 0.060 |
Why?
|
Menopause | 1 | 2012 | 1651 | 0.060 |
Why?
|
Rare Diseases | 1 | 2010 | 630 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6856 | 0.060 |
Why?
|
Vitamin D | 1 | 2018 | 3311 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2437 | 0.060 |
Why?
|
Karnofsky Performance Status | 2 | 2015 | 167 | 0.060 |
Why?
|
Disease Progression | 5 | 2019 | 13655 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12096 | 0.060 |
Why?
|
HIV Infections | 1 | 2010 | 17564 | 0.050 |
Why?
|
Low Back Pain | 1 | 2012 | 989 | 0.050 |
Why?
|
International Agencies | 2 | 2018 | 245 | 0.050 |
Why?
|
Time Factors | 5 | 2019 | 40271 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2009 | 792 | 0.050 |
Why?
|
Health Status | 4 | 2006 | 4096 | 0.050 |
Why?
|
Drug Utilization | 1 | 2009 | 1192 | 0.050 |
Why?
|
Infant | 6 | 2017 | 36497 | 0.050 |
Why?
|
Gene Frequency | 3 | 2012 | 3615 | 0.050 |
Why?
|
HIV | 1 | 2010 | 1596 | 0.050 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 982 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2016 | 36840 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3308 | 0.050 |
Why?
|
Prevalence | 3 | 2014 | 15880 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2544 | 0.050 |
Why?
|
Hepatic Artery | 1 | 2023 | 232 | 0.050 |
Why?
|
Genetic Variation | 4 | 2019 | 6610 | 0.050 |
Why?
|
Lod Score | 2 | 2012 | 600 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9623 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2017 | 26395 | 0.050 |
Why?
|
Genome, Human | 2 | 2011 | 4453 | 0.050 |
Why?
|
Mass Screening | 3 | 2008 | 5455 | 0.050 |
Why?
|
Genes, Dominant | 3 | 1994 | 856 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9507 | 0.040 |
Why?
|
Somatostatin | 1 | 2022 | 448 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2006 | 11249 | 0.040 |
Why?
|
Intracranial Hemorrhages | 2 | 2016 | 815 | 0.040 |
Why?
|
Skull Base | 1 | 2023 | 294 | 0.040 |
Why?
|
Age Distribution | 1 | 2006 | 2881 | 0.040 |
Why?
|
Apoptosis | 1 | 2016 | 9526 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5532 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 2127 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2018 | 323 | 0.040 |
Why?
|
Child | 8 | 2017 | 80863 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2863 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2023 | 708 | 0.040 |
Why?
|
Metabolism | 1 | 2020 | 193 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 350 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 952 | 0.040 |
Why?
|
Propensity Score | 2 | 2017 | 1971 | 0.040 |
Why?
|
Progesterone | 1 | 2022 | 750 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2023 | 1085 | 0.040 |
Why?
|
Faculty, Medical | 1 | 1987 | 1218 | 0.040 |
Why?
|
Israel | 2 | 2013 | 726 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2018 | 310 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 640 | 0.040 |
Why?
|
Necrosis | 1 | 2001 | 1621 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2018 | 520 | 0.030 |
Why?
|
Signal Transduction | 2 | 2019 | 23638 | 0.030 |
Why?
|
Body Constitution | 1 | 1997 | 273 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2018 | 453 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 83 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2011 | 4533 | 0.030 |
Why?
|
Life Tables | 1 | 1996 | 368 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1328 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2519 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10845 | 0.030 |
Why?
|
Postural Balance | 2 | 1996 | 638 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 2910 | 0.030 |
Why?
|
Aging | 2 | 1992 | 8761 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 76 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 631 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 732 | 0.030 |
Why?
|
Fibrosis | 1 | 2001 | 2076 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2015 | 2964 | 0.030 |
Why?
|
New England | 1 | 2017 | 1056 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 474 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 564 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 751 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2656 | 0.030 |
Why?
|
Platelet Count | 1 | 2016 | 786 | 0.030 |
Why?
|
Selection Bias | 1 | 2015 | 360 | 0.030 |
Why?
|
Oligodendroglioma | 1 | 2014 | 278 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 2034 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2001 | 3637 | 0.030 |
Why?
|
Diseases in Twins | 1 | 1995 | 447 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2015 | 395 | 0.030 |
Why?
|
Internationality | 1 | 2018 | 1007 | 0.030 |
Why?
|
Calcinosis | 1 | 2001 | 1485 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2017 | 0.030 |
Why?
|
Health Services for the Aged | 1 | 1994 | 258 | 0.020 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2000 | 1041 | 0.020 |
Why?
|
Genomic Instability | 1 | 2016 | 714 | 0.020 |
Why?
|
Likelihood Functions | 2 | 2012 | 993 | 0.020 |
Why?
|
Nuclear Family | 1 | 1993 | 311 | 0.020 |
Why?
|
Geriatric Assessment | 2 | 1996 | 1422 | 0.020 |
Why?
|
Hematoma | 1 | 2016 | 768 | 0.020 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 1995 | 388 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8051 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 1996 | 802 | 0.020 |
Why?
|
Laminectomy | 1 | 2012 | 226 | 0.020 |
Why?
|
Craniocerebral Trauma | 1 | 1995 | 496 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2633 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 712 | 0.020 |
Why?
|
Housing | 1 | 1995 | 679 | 0.020 |
Why?
|
Denmark | 1 | 2013 | 778 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2408 | 0.020 |
Why?
|
Phosphorylation | 2 | 2016 | 8332 | 0.020 |
Why?
|
Sweden | 1 | 2013 | 1382 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2742 | 0.020 |
Why?
|
Premenopause | 1 | 1994 | 1039 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 1996 | 1158 | 0.020 |
Why?
|
Dystonia Musculorum Deformans | 1 | 1990 | 158 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1898 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1750 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1119 | 0.020 |
Why?
|
Environment | 1 | 1995 | 1126 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1993 | 1390 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 1997 | 983 | 0.020 |
Why?
|
Life Style | 1 | 2020 | 3929 | 0.020 |
Why?
|
Jews | 1 | 1990 | 358 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2666 | 0.020 |
Why?
|
American Cancer Society | 1 | 2008 | 69 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2011 | 738 | 0.020 |
Why?
|
Home Care Services | 1 | 1994 | 655 | 0.020 |
Why?
|
Health Education | 1 | 1994 | 1059 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3619 | 0.020 |
Why?
|
Cluster Analysis | 1 | 1995 | 2731 | 0.020 |
Why?
|
Genetic Testing | 1 | 2001 | 3586 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2508 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 151 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2450 | 0.020 |
Why?
|
Tissue Donors | 1 | 1997 | 2377 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8510 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2051 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3335 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9791 | 0.020 |
Why?
|
Regression Analysis | 2 | 1997 | 6353 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6320 | 0.020 |
Why?
|
Graft Survival | 1 | 1997 | 3890 | 0.020 |
Why?
|
Haplotypes | 1 | 2012 | 2725 | 0.020 |
Why?
|
Consensus | 1 | 2016 | 3207 | 0.020 |
Why?
|
Population Surveillance | 1 | 2016 | 2601 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 1990 | 1727 | 0.020 |
Why?
|
Marriage | 1 | 1987 | 352 | 0.020 |
Why?
|
Overweight | 1 | 2016 | 2428 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 1996 | 3611 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2018 | 3974 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1991 | 1797 | 0.010 |
Why?
|
Genetic Diseases, Inborn | 1 | 1989 | 604 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2016 | 3202 | 0.010 |
Why?
|
North America | 1 | 2007 | 1292 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4780 | 0.010 |
Why?
|
Graft Rejection | 1 | 1997 | 4505 | 0.010 |
Why?
|
Data Collection | 1 | 1993 | 3329 | 0.010 |
Why?
|
Fractures, Bone | 1 | 1995 | 2063 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4948 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2009 | 1095 | 0.010 |
Why?
|
Animals | 2 | 2016 | 169418 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1998 | 15460 | 0.010 |
Why?
|
Mothers | 1 | 1993 | 2210 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4120 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1994 | 3590 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1997 | 4285 | 0.010 |
Why?
|
Kidney | 1 | 1997 | 7064 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10601 | 0.010 |
Why?
|
Carcinoma | 1 | 1993 | 2341 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6091 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5342 | 0.010 |
Why?
|
Europe | 1 | 2007 | 3439 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8081 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2733 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10865 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17149 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5808 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20762 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2785 | 0.010 |
Why?
|
Perception | 1 | 2004 | 1207 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2000 | 581 | 0.010 |
Why?
|
Transcription Factors | 1 | 1996 | 12174 | 0.010 |
Why?
|
Body Surface Area | 1 | 1997 | 207 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 5043 | 0.010 |
Why?
|
Electrocardiography | 1 | 2009 | 6410 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2004 | 2239 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12242 | 0.010 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 1993 | 192 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 1987 | 3922 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1993 | 767 | 0.010 |
Why?
|
Health Maintenance Organizations | 1 | 1994 | 658 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1993 | 1305 | 0.010 |
Why?
|
Drug Therapy | 1 | 1994 | 504 | 0.010 |
Why?
|
Mice | 1 | 2016 | 82045 | 0.000 |
Why?
|
Physicians | 1 | 1987 | 4615 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1749 | 0.000 |
Why?
|
Exercise Therapy | 1 | 1994 | 941 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1995 | 6242 | 0.000 |
Why?
|
Genes, Recessive | 1 | 1989 | 625 | 0.000 |
Why?
|
Body Weight | 1 | 1997 | 4630 | 0.000 |
Why?
|
Chronic Disease | 1 | 1997 | 9382 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2000 | 15965 | 0.000 |
Why?
|